William Shell is CEO & Chief Scientific Officer & 10% at Targeted Medical Pharma, Inc. (NONE). They have made 5 open-market trades across 2 companies since 2013, most recently 2014-05-28.
CIK 0001509917
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $269K since 2013, against 4 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| PrivateUnlisted | 6,500 | — |
| TRGM | 664,764 | — |
| Total | $0 |
Shares reported on the most recent Form 4, priced at the 2014-05-28 close. 2 holdings could not be priced and are excluded from the total.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| TRGM | SELL | 2014-05-28 | 2014-05-28 | $0.60 | $1K | N/A | N/A | N/A |
| TRGM | SELL | 2014-05-27 | 2014-05-27 | $0.65 | $2K | N/A | N/A | N/A |
| TRGM | SELL | 2014-04-10 | 2014-04-10 | $0.60 | $90K | N/A | N/A | N/A |
| TRGM | SELL | 2013-09-13 | 2013-09-20 | $0.84 | $2K | N/A | N/A | N/A |
| PrivateTargeted Medical Pharma, Inc. | BUY | 2013-01-11 | 2013-07-23 | $1.69 | $269K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.